Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Albina Nowak

Showing results (31-40 of 105) with videos related to

Pageof 11
Sort By:
BMJ Open|June 3, 2019
Management of hyperglycaemia in persons with non-insulin-dependent type 2 diabetes mellitus who are started on systemic glucocorticoid therapy: a systematic reviewMilos Tatalovic, Roger Lehmann, Marcus Cheetham, et al.
Praxis|September 13, 2013
[Atrioventricular nodal re-entry tachycardia]Simon Andreas Müggler, Sarah Marlène Iseli, Claudine Meindl-Fridez, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|March 2, 2023
Deep next-generation proteomics and network analysis reveal systemic and tissue-specific patterns in Fabry diseaseAbdellah Tebani, Frédéric Barbey, Olivier Dormond, et al.
Kidney & Blood Pressure Research|March 3, 2017
Disease Progression Modeling to Evaluate the Effects of Enzyme Replacement Therapy on Kidney Function in Adult Patients with the Classic Phenotype of Fabry DiseaseAlbina Nowak, Gilbert Koch, Uyen Huynh-Do, et al.
Journal of Inherited Metabolic Disease|August 27, 2019
Fabry disease genotype, phenotype, and migalastat amenability: Insights from a national cohortAlbina Nowak, Uyen Huynh-Do, Pierre-Alexandre Krayenbuehl, et al.
International Journal of Cardiology|April 12, 2023
Clinical and CMR characteristics associated with cardiac events in patients with Fabry diseaseRoxana Hiestand, Albina Nowak, Justyna M Sokolska, et al.
Clinical Chemistry|October 11, 2014
G-protein receptor kinase 4 polymorphism and response to antihypertensive therapyAnne M Muskalla, Paolo M Suter, Matthias Saur, et al.
Kidney & Blood Pressure Research|December 23, 2014
Mortality prediction using modern peptide biomarkers in hemodialysis patients--a comparative analysisFerruh Artunc, Albina Nowak, Christian Müller, et al.
Sleep & Breathing = Schlaf & Atmung|April 3, 2019
Obstructive sleep apnea and quality of life in Fabry disease: a prospective parallel cohort studyThomas Gaisl, Albina Nowak, Noriane A Sievi, et al.
Kidney & Blood Pressure Research|May 23, 2015
Sclerostin quo vadis? - is this a useful long-term mortality parameter in prevalent hemodialysis patients?Albina Nowak, Ferruh Artunc, Andreas L Serra, et al.
Pageof 11

Showing results (31-40 of 105) with videos related to

Sort By:
Pageof 11
BMJ Open|June 3, 2019
Management of hyperglycaemia in persons with non-insulin-dependent type 2 diabetes mellitus who are started on systemic glucocorticoid therapy: a systematic reviewMilos Tatalovic, Roger Lehmann, Marcus Cheetham, et al.
Praxis|September 13, 2013
[Atrioventricular nodal re-entry tachycardia]Simon Andreas Müggler, Sarah Marlène Iseli, Claudine Meindl-Fridez, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|March 2, 2023
Deep next-generation proteomics and network analysis reveal systemic and tissue-specific patterns in Fabry diseaseAbdellah Tebani, Frédéric Barbey, Olivier Dormond, et al.
Kidney & Blood Pressure Research|March 3, 2017
Disease Progression Modeling to Evaluate the Effects of Enzyme Replacement Therapy on Kidney Function in Adult Patients with the Classic Phenotype of Fabry DiseaseAlbina Nowak, Gilbert Koch, Uyen Huynh-Do, et al.
Journal of Inherited Metabolic Disease|August 27, 2019
Fabry disease genotype, phenotype, and migalastat amenability: Insights from a national cohortAlbina Nowak, Uyen Huynh-Do, Pierre-Alexandre Krayenbuehl, et al.
International Journal of Cardiology|April 12, 2023
Clinical and CMR characteristics associated with cardiac events in patients with Fabry diseaseRoxana Hiestand, Albina Nowak, Justyna M Sokolska, et al.
Clinical Chemistry|October 11, 2014
G-protein receptor kinase 4 polymorphism and response to antihypertensive therapyAnne M Muskalla, Paolo M Suter, Matthias Saur, et al.
Kidney & Blood Pressure Research|December 23, 2014
Mortality prediction using modern peptide biomarkers in hemodialysis patients--a comparative analysisFerruh Artunc, Albina Nowak, Christian Müller, et al.
Sleep & Breathing = Schlaf & Atmung|April 3, 2019
Obstructive sleep apnea and quality of life in Fabry disease: a prospective parallel cohort studyThomas Gaisl, Albina Nowak, Noriane A Sievi, et al.
Kidney & Blood Pressure Research|May 23, 2015
Sclerostin quo vadis? - is this a useful long-term mortality parameter in prevalent hemodialysis patients?Albina Nowak, Ferruh Artunc, Andreas L Serra, et al.
Pageof 11